PBH

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

Retrieved on: 
Thursday, April 25, 2024

TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close.

Key Points: 
  • TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close.
  • The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m.
  • The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com .
  • To participate via phone, listeners calling from the U.S. and Canada may dial 800-715-9871 using the conference ID 4304270.

Fanatics Betting and Gaming Closes its Acquisition of the US Businesses of PointsBet

Retrieved on: 
Wednesday, April 3, 2024

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Today, Fanatics Betting and Gaming (FBG), a subsidiary of Fanatics Holdings Inc., closed on the final state, Illinois, in its previously announced acquisition of the U.S. businesses of PointsBet.

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Today, Fanatics Betting and Gaming (FBG), a subsidiary of Fanatics Holdings Inc., closed on the final state, Illinois, in its previously announced acquisition of the U.S. businesses of PointsBet.
  • Fanatics Betting and Gaming will also provide the betting operations to nineteen retail locations, including the only retail sportsbook inside an NFL stadium at Commanders Field in Maryland.
  • “The acquisition of the US businesses of PointsBet has super charged our expansion plans,” said Matt King, CEO of Fanatics Betting and Gaming.
  • Fanatics Betting and Gaming has also produced exclusive casino content including the popular Fanatics Blackjack game developed in partnership with Boom Entertainment.

PREMIUM BRANDS HOLDINGS CORPORATION TO RELEASE FOURTH QUARTER 2023 RESULTS

Retrieved on: 
Friday, February 23, 2024

VANCOUVER, BC, Feb. 23, 2024 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its fourth quarter 2023 results on Friday, March 15, 2024.

Key Points: 
  • VANCOUVER, BC, Feb. 23, 2024 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its fourth quarter 2023 results on Friday, March 15, 2024.
  • Mr. George Paleologou, President and CEO and Mr. Will Kalutycz, CFO will host a live question and answer session at 10:30 a.m. Vancouver time (1:30p.m.
  • Toronto Time) on Friday, March 15, 2024.
  • Alternatively, a recording of the question and answer session will be available at the Company's website at http://www.premiumbrandsholdings.com .

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, February 8, 2024

Third Fiscal Quarter Ended December 31, 2023

Key Points: 
  • Third Fiscal Quarter Ended December 31, 2023
    Reported revenues in the third quarter of fiscal 2024 of $282.7 million compared to a $275.5 million in the third quarter of fiscal 2023.
  • Diluted earnings per share of $1.06 for the third quarter of fiscal 2024 increased 2.2% versus $1.04 in the prior year comparable period.
  • Non-GAAP free cash flow in the third quarter of fiscal 2024 was $69.5 million, compared to $53.1 million in the prior year third quarter.
  • International OTC Healthcare: Fiscal third quarter 2024 segment revenues were $46.2 million, compared to $38.6 million reported in the prior year comparable period.

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

Retrieved on: 
Wednesday, January 10, 2024

TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday, February 8, 2024 before the opening of the market.

Key Points: 
  • TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday, February 8, 2024 before the opening of the market.
  • The Company will host a conference call to discuss the results that same morning at 8:30 a.m.
  • To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com .
  • To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin.

PREMIUM BRANDS HOLDINGS CORPORATION APPOINTS NEW DIRECTOR TO ITS BOARD

Retrieved on: 
Friday, December 1, 2023

VANCOUVER, BC, Dec. 1, 2023 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, is pleased to announce that its Board of Directors has appointed Mr. Thomas P. Dea as an independent non-executive director of the Corporation effective December 1, 2023.

Key Points: 
  • VANCOUVER, BC, Dec. 1, 2023 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, is pleased to announce that its Board of Directors has appointed Mr. Thomas P. Dea as an independent non-executive director of the Corporation effective December 1, 2023.
  • Mr. Dea is a long term shareholder of Premium Brands in his personal capacity and has extensive experience as a director of private and public companies, including as Chairman.
  • He was also a Managing Director at Onex Corporation.
  • His long history of leadership, along with his extensive board experience and deep knowledge of corporate finance will be invaluable to Premium Brands as we continue to meet our strategic goals."

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, November 2, 2023

Second Fiscal Quarter Ended September 30, 2023

Key Points: 
  • Second Fiscal Quarter Ended September 30, 2023
    Reported revenues in the second quarter of fiscal 2024 of $286.3 million compared to a record $289.3 million in the second quarter of fiscal 2023.
  • Reported net income for the second quarter of fiscal 2024 totaled $53.6 million, compared to the prior year second quarter’s net income of $51.0 million.
  • Non-GAAP free cash flow in the second quarter of fiscal 2024 was $59.5 million compared to $55.2 million in the prior year second quarter.
  • International OTC Healthcare: Fiscal second quarter 2024 segment revenues were $41.9 million compared to $37.2 million reported in the prior year comparable period.

PREMIUM BRANDS HOLDINGS CORPORATION TO RELEASE THIRD QUARTER 2023 RESULTS

Retrieved on: 
Wednesday, November 1, 2023

VANCOUVER, BC, Nov. 1, 2023 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its third quarter 2023 results on Tuesday, November 14, 2023.

Key Points: 
  • VANCOUVER, BC, Nov. 1, 2023 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its third quarter 2023 results on Tuesday, November 14, 2023.
  • Mr. George Paleologou, President and CEO and Mr. Will Kalutycz, CFO will host a live question and answer session at 10:30 a.m. Vancouver time (1:30p.m.
  • Toronto Time) on Tuesday, November 14, 2023.
  • Alternatively, a recording of the question and answer session will be available at the Company's website at http://www.premiumbrandsholdings.com .

MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

Retrieved on: 
Monday, October 9, 2023

“We are pleased to advance our second innovative PEP candidate, MBX 1416, into the clinic with the initiation of the Phase 1/2 clinical trial,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences.

Key Points: 
  • “We are pleased to advance our second innovative PEP candidate, MBX 1416, into the clinic with the initiation of the Phase 1/2 clinical trial,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences.
  • “This milestone is an important step toward bringing a potential solution to patients with PBH, for which there are no currently approved therapies.
  • The trial is being conducted in the United States and is designed to enroll approximately 56 participants.
  • More information on the Phase 1/2 study can be found at www.clinicaltrials.gov , identifier NCT06036784 .

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

Retrieved on: 
Thursday, October 5, 2023

TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market.

Key Points: 
  • TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market.
  • The Company will host a conference call to discuss the results that same morning at 8:30 a.m.
  • To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com .
  • To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin.